BURDEN OF ILLNESS, ANNUAL HEALTHCARE UTILIZATION, AND COSTS ASSOCIATED WITH COMMERCIALLY INSURED PATIENTS WITH CUSHING DISEASE IN THE UNITED STATES

被引:12
|
作者
Broder, Michael S. [1 ]
Neary, Maureen P. [2 ]
Chang, Eunice [1 ]
Cherepanov, Dasha [1 ]
Ludlam, William H. [2 ]
机构
[1] Partnership Hlth Analyt Res LLC, Beverly Hills, CA USA
[2] Novartis Pharmaceut, E Hanover, NJ 07936 USA
关键词
MORBIDITY; MORTALITY;
D O I
10.4158/EP14126.OR
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe the burden of illness, healthcare utilization, and costs associated with Cushing disease (CD), a rare disorder resulting from adrenocorticotropic hormone secreting pituitary tumors, in commercially insured patients in the U.S. Methods: Patients with CD were identified in 2010 in the IMS Health PharMetrics and Truven Health Analytics MarketScan claims databases. Because there is no diagnosis code l'or CD, patients were identified with a claim for Cushing syndrome and either benign pituitary adenoma or hypophysectomy. We estimated total and CD-related utilization and costs using pharmacy and medical claims. Results: We identified 685 CD patients (81% female; mean age, 41.7 years; mean ('hanson comorbidity index, 1.6; mean number of chronic conditions, 4.2); 30.5% of the patients had diabetes, 22.5% had psychiatric disturbances, 21% had infections, 8.6% had osteoporosis, 8% had cardiovascular disease stroke, 5.5(.74) had kidney stones, and 0.7'7i-) had compression fracture of a vertebra. Patients had a mean of 19.8 of visits per year; 38.4% had inpatient hospitalizations and 34.2% visited the emergency department (ED). Patients had a mean of 3.2 CD-related of visits per year; 26.9% had CD-related hospitalizations, 0.9% had CD-related ED visits, and 36.8% had CD treatments. 1\ lean annual total costs were 534,992 (pharmacy, $3,597; medical costs, $31,395). C[) related costs accounted for $14,310 of total costs (CD treatment costs, $9,353; other CD-related costs, $4,957). Conclusion: cD patients have a high burden of illness. Among CT) patients in this study, 30.5% had diabetes, 22.5'i-) had psychiatric disturbances, 21% had infections, 8.6% had osteoporosis, 8% had cardiovascular disease/ stroke, and 5.5c;70 had kidney stones. Patients had 19.8 office visits per year, and >34% of patients were hospitalized. Mean total cost of care was approximately $35,000 per year.
引用
收藏
页码:77 / 86
页数:10
相关论文
共 50 条
  • [1] PREVALENCE AND HEALTHCARE UTILIZATION BURDEN ASSOCIATED WITH RHINOSINUSITIS IN A UNITED STATES COMMERCIALLY INSURED POPULATION
    Khanna, R.
    Holy, C. E.
    Romano, A.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A349 - A349
  • [2] Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
    Mohamed I. Elsaid
    You Li
    Carolyn Catalano
    Carlos D. Minacapelli
    Kapil Gupta
    Vinod K. Rustgi
    [J]. PharmacoEconomics - Open, 2021, 5 : 89 - 100
  • [3] Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
    Elsaid, Mohamed I.
    Li, You
    Catalano, Carolyn
    Minacapelli, Carlos D.
    Gupta, Kapil
    Rustgi, Vinod K.
    [J]. PHARMACOECONOMICS-OPEN, 2021, 5 (01) : 89 - 100
  • [4] HEALTHCARE RESOURCE UTILIZATION AMONG COMMERCIALLY INSURED COLD AGGLUTININ DISEASE PATIENTS IN THE UNITED STATES
    Su, J.
    Bylsma, L. C.
    Jiang, X.
    Arias, Morales J.
    Jain, N.
    Nordyke, R.
    [J]. VALUE IN HEALTH, 2019, 22 : S348 - S348
  • [5] Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States
    Su, Jun
    Bylsma, Lauren C.
    Jiang, Xiaohui
    Morales Arias, Jaime
    Jain, Nisha
    Nordyke, Robert J.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (08) : 902 - 907
  • [6] ANNUAL HEALTH CARE UTILIZATION AND COSTS IN CUSHING'S DISEASE PATIENTS IN THE UNITED STATES
    Broder, M.
    Neary, M. P.
    Chang, E.
    Ludlam, W.
    Cherepanov, D.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A162 - A162
  • [7] Burden of Essential Tremor: Associated Morbidities, Healthcare Resource Utilization and Costs in Commercially Insured Patients on Drug Therapy
    Hennum, Liana
    Samiian, Ali
    Khosla, Dhira
    Louis, Elan
    [J]. NEUROLOGY, 2023, 100 (17)
  • [8] HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG COMMERCIALLY INSURED PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN THE UNITED STATES
    Bonafede, M. M.
    McMorrow, D.
    Marshall, A.
    Gupta, K.
    Pazirandeh, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S125 - S125
  • [9] Healthcare Utilization and Costs in Commercially Insured Patients with AL Amyloidosis
    Quock, Tiffany P.
    Yan, Jessie T.
    Chang, Eunice
    Guthrie, Spencer D.
    Broder, Michael S.
    [J]. BLOOD, 2017, 130
  • [10] HEALTHCARE COST AND UTILIZATION OF HEPATIC ENCEPHALOPATHY: ANALYSIS OF COMMERCIALLY INSURED PATIENTS IN THE UNITED STATES
    Elsaid, Mohamed I.
    Li, You
    John, Tina
    Pentakota, Ram
    Rustgi, Vinod K.
    [J]. HEPATOLOGY, 2019, 70 : 261A - 261A